Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Allogenic Bone Marrow Transplantation”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT00038805
What this trial is testing

Nonmyeloablative Preparative Regimen Using Mylotarg for Patients With High Risk Acute Myeloid Leukemia (AML), Acute Lymphocytic Leukemia (ALL), Chronic Myeloid Leukemia (CML) and Myelodysplastic Syndrome (MDS)

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 3
Not applicableUnknownNCT02320942
What this trial is testing

Exercise Post Bone Marrow Transplant

Who this might be right for
Leukemia
University of British Columbia 20
Very early researchStudy completedNCT00426517
What this trial is testing

Donor Stem Cell Transplantation for Congenital Immunodeficiencies

Who this might be right for
Inherited Immune Deficiencies
National Institute of Allergy and Infectious Diseases (NIAID) 48
Testing effectiveness (Phase 2)Study completedNCT00136903
What this trial is testing

Safety and Efficacy Study of Adult Human Mesenchymal Stem Cells to Treat Acute Graft Versus Host Disease (GVHD)

Who this might be right for
Graft Vs Host Disease
Mesoblast, Inc. 32
Testing effectiveness (Phase 2)Study completedNCT00208923
What this trial is testing

Allogeneic Bone Marrow Transplantation With Matched Unrelated Donors for Patients With Hematologic Malignancies

Who this might be right for
Hematologic Malignancies
Emory University 55
Testing effectiveness (Phase 2)Study completedNCT01249820
What this trial is testing

Pharmacokinetics of Anidulafungin (Ecalta ®) Intravenous Given to Patients at High Risk for Developing Invasive Fungal Disease

Who this might be right for
LeukemiaMyelodysplastic SyndromeLeukemia, Myeloid, Acute
Radboud University Medical Center 26
Testing effectiveness (Phase 2)Study completedNCT00750659
What this trial is testing

Nilotinib Pre and Post Allogeneic Stem Cell Transplantation

Who this might be right for
Chronic Myeloid LeukemiaAcute Lymphoblastic LeukemiaStem Cell Transplantation
Sheba Medical Center 24
Testing effectiveness (Phase 2)Study completedNCT00427557
What this trial is testing

Cellular Therapy With Cord Blood Cells

Who this might be right for
Multiple MyelomaLeukemiaLymphoma
M.D. Anderson Cancer Center 31
Testing effectiveness (Phase 2)Ended earlyNCT01159067
What this trial is testing

Deferasirox for Treating Patients Who Have Undergone Allogeneic Stem Cell Transplant and Have Iron Overload

Who this might be right for
Iron OverloadAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in Remission+99 more
City of Hope Medical Center 1
Early research (Phase 1)Looking for participantsNCT04375631
What this trial is testing

CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia

Who this might be right for
Recurrent Acute Myeloid LeukemiaRecurrent Chronic Myelomonocytic LeukemiaRecurrent Myelodysplastic Syndrome+6 more
Fred Hutchinson Cancer Center 120
Early research (Phase 1)Study completedNCT02083250
What this trial is testing

Fludarabine Phosphate, Clofarabine, and Busulfan With Vorinostat in Treating Patients With Acute Leukemia in Remission or Relapse Undergoing Donor Stem Cell Transplant

Who this might be right for
Acute Lymphoblastic Leukemia in RemissionAcute Myeloid Leukemia in RemissionAllogeneic Hematopoietic Stem Cell Transplantation Recipient+4 more
M.D. Anderson Cancer Center 70
Not applicableUnknownNCT02900768
What this trial is testing

Effects of Exercise on Allogeneic Stem Cell Transplant

Who this might be right for
Hematological Malignancy
Raewyn Broady 120
Testing effectiveness (Phase 2)Study completedNCT02566304
What this trial is testing

Reduced Intensity Chemotherapy and Radiation Therapy Before Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies

Who this might be right for
Acute Myeloid LeukemiaAcute Myeloid Leukemia in RemissionAplastic Anemia+12 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 35
Testing effectiveness (Phase 2)Study completedNCT01885897
What this trial is testing

IL-15 Super Agonist ALT-803 to Treat Relapse Of Hematologic Malignancy After Allogeneic SCT

Who this might be right for
Acute Myelogenous Leukemia (AML)Acute Lymphoblastic Leukemia (ALL)Myelodysplastic Syndromes (MDS)+4 more
Masonic Cancer Center, University of Minnesota 33
Early research (Phase 1)Study completedNCT00677859
What this trial is testing

Safety Study of MultiStem® in Patients With Acute Leukemia, Chronic Myeloid Leukemia, or Myelodysplasia

Who this might be right for
Hematologic Malignancies
Healios K.K. 36
Testing effectiveness (Phase 2)Active Not RecruitingNCT01744223
What this trial is testing

Safety Study of Gene Modified Donor T-cells Following Partially Mismatched Stem Cell Transplant

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myelogenous LeukemiaLymphoma+1 more
Bellicum Pharmaceuticals 36
Testing effectiveness (Phase 2)Ended earlyNCT01118013
What this trial is testing

Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Malignancies or Secondary Myelodysplasia Previously Treated With High-Dose Chemotherapy and Autologous Stem Cell Transplant

Who this might be right for
LeukemiaLymphomaLymphoproliferative Disorder+3 more
Alliance for Clinical Trials in Oncology 6
Testing effectiveness (Phase 2)Ended earlyNCT05918055
What this trial is testing

Eltanexor (KPT-8602) With Inqovi (Decitabine-Cedazuridine) in High-Risk Myelodysplastic Syndromes

Who this might be right for
Myelodysplastic Syndromes
National Cancer Institute (NCI) 3
Testing effectiveness (Phase 2)Study completedNCT00053989
What this trial is testing

NMA Allogeneic Hematopoietic Cell Transplant in Hematologic Cancer/Disorders

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+5 more
Roswell Park Cancer Institute 41
Testing effectiveness (Phase 2)Study completedNCT02117297
What this trial is testing

SCT Plus Immune Therapy in Average Risk AML/MDS

Who this might be right for
Acute Myelogenous LeukemiaMyelodysplastic Syndrome
New York Medical College 26
Next Page